Padraig O'Suilleabhain, M.D. Titles and Appointments Professor School Medical School Department Neurology You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Joined UT Southwestern: 1998 Clinical Interests: Parkinson Disease Essential Tremor Normal Pressure Hydrocephalus Dystonia Research: Diagnosis and prognosis in NPH hydrocephalus High intensity focused ultrasound for treating movement disorders Trainee Education A mentor in the Academic Colleges program since 2016 Education Medical School University of Dublin (1991) Internship St. James's Hospital (1992), Medicine Internship Mayo Clinic School of Graduate Medical Education (1993), Medicine Residency Mayo Clinic School of Graduate Medical Education (1996), Neurology Fellowship Mayo Clinic School of Graduate Medical Education (1997), Movement Disorders Research Fellowship Mayo Clinic School of Graduate Medical Education (1998), Neurology Other Post Graduate Training The University of Texas at Dallas (2015), Health Sector Management Research Interest Magnetoencephalography investigating motor control in normal writing and dystonic writing Neuroprotection / disease modification in Progressive Supranuclear Palsy Normal Pressure Hydrocephalus diagnosis and treatment Parkinson disease pharmacotherapy Publications Plasma glial fibrillary acidic protein as a biomarker of acute focal brain injury after high-intensity focused ultrasound thalamotomy Saez-Calveras N, Asturias A, Yu J, Stopchinski B, Vaquer-Alicea J, O'Suilleabhain PE, Mckenzie L, Viera J, Diamond MI, Shah BR Brain Communications 2025 Mar 7 Audible tremor: Analysis of the validity of audible information in assessing tremor severity Grill N, Wainman E, Sharma VD, O'Suilleabhain P, Louis ED Parkinsonism and Related Disorders 2025 Mar 132 Plasma glial fibrillary acidic protein as a biomarker of acute focal brain injury after high-intensity focused ultrasound thalamotomy Saez-Calveras N, Asturias A, Yu J, Stopschinski B, Vaquer-Alicea J, O'Suilleabhain P, McKenzie L, Viera J, Diamond MI, Shah BR Brain Communications 2025 7 Mesdopetam for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease: A Randomized Phase 2b Trial Antonini A, O'Suilleabhain P, Stocchi F, Landström J, Waters S, Sonesson C, Tedroff J Movement Disorders Clinical Practice 2025 Magnetic Resonance Imaging Measures to Track Atrophy Progression in Progressive Supranuclear Palsy in Clinical Trials Author Collaboration tA, Quattrone A, Franzmeier N, Huppertz HJ, Klietz M, Roemer SN, Williams D, Lafontaine AL, Marras C, Jog M, Panisset M, Lang A, Parker L, Stewart AJ, Corvol JC, Azulay JP, Couratier P, Mollenhauer B, Lorenzl S, Ludolph A, Benecke R, Höglinger G, Lipp A, Reichmann H, Woitalla D, Chan D, Zermansky A, Burn D, Lees A, Boxer A, Miller BL, Lobach IV, Roberson E, Honig L, Zamrini E, Pahwa R, Bordelon Y, Driver-Dunkley E, Lessig S, Lew M, Womack K, Boeve B, Ferrara J, Hillis A, Kaufer D, Kumar R, Xie T, Gunzler S, Zesiewicz T, Dayalu P, O'Suilleabhain P Movement Disorders 2024 Aug 39 1329-1342 First High Intensity Focused Ultrasound Thalamotomy in a Patient with Cerebral Aneurysms Feltrin FS, White A, O'Suilleabhain P, Mckenzie L, Pride L, Shah BR Movement Disorders Clinical Practice 2024 Apr 11 444-446 Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial (Nature Medicine, (2021), 27, 8, (1451-1457), 10.1038/s41591-021-01455-x) Author Collaboration PS, Dam T, Boxer AL, Golbe LI, Höglinger GU, Morris HR, Litvan I, Lang AE, Corvol JC, Aiba I, Grundman M, Yang L, Tidemann-Miller B, Kupferman J, Harper K, Kamisoglu K, Wald MJ, Graham DL, Gedney L, O’Gorman J, Haeberlein SB, Aiba I, Antonini A, Apetauerova D, Azulay JP, Martinez EB, Bang J, Barone P, Barrett M, Bega D, Berg D, Corrales KB, Bordelon Y, Boxer AL, Brandt M, Brueggemann N, Castelnovo G, Ceravolo R, Chuang R, Chung SJ, Church A, Corvol JC, Cudia P, Dale M, Defebvre L, Drapier S, Driver-Dunckley ED, Ebersbach G, Eggert KM, Ellenbogen A, O’Suilleabhain P Nature medicine 2023 Nov 29 2955-2956 ELectronic Archimedes spiral Neural Network (ELANN) Holcomb JM, Maldjian JA, Xi Y, O'Suilleabhain PE, Louis ED, Shah BR Parkinsonism and Related Disorders 2023 Oct 115 Stigma and Social Avoidance in Adults with Essential Tremor O'Suilleabhain P, Berry DS, Lundervold DA, Turner TH, Tovar M, Louis ED Movement Disorders Clinical Practice 2023 Sep 10 1317-1323 Improving tremor response to focused ultrasound thalamotomy Holcomb JM, Chopra R, Feltrin FS, Elkurd MT, El-Nazer R, Mckenzie L, O'suilleabhain P, Maldjian JA, Dauer W, Shah BR Brain Communications 2023 5 Results 1-10 of 52 1 2 3 4 5 Next Last Books Featured Books Sensory disturbance in Parkinson's disease. In Parkinson's Disease (Second Edition) O'Suilleabhain PE (2013). Boca Raton, CRC Press LLC Adjunctive therapies in Parkinson?s disease. In Parkinson?s Disease and Movement Disorders: Diagnosis and Treatment Guidelines for the Practicing Physician O'Suilleabhain PE, Murphy SM (2000). Humana Press Sensory Disturbance in Parkinson's disease. In Parkinson's Disease O'Suilleabhain PE (2005). Boca Raton, CRC Press LLC Chorea. In Handbook of Movement Disorders O'Suilleabhain PE (2011). New York, Oxford American Neurology Library Professional Associations/Affiliations American Association of Neurologists American Medical Association Dallas County Medical Society Movement Disorder Society Texas Neurological Society
